Intercellular interactions and progression of hormonal resistance of breast cancer cells

Intercellular interactions and progression of hormonal resistance of breast cancer cells

Bibliographic Details
Main Authors:	S. E. Semina, D. V. Bagrov, M. A. Krasil’nikov
Format:	Article
Language:	Russian
Published:	ABV-press 2015-06-01
Series:	Успехи молекулярной онкологии
Subjects:	рак молочной железы гормональная резистентность тамоксифен экзосомы микрорнк рецептор эстрогена межклеточные взаимодействия
Online Access:	https://umo.abvpress.ru/jour/article/view/31

Similar Items

COMPARATIVE ANALYSIS OF THE EXOSOMAL CARGO OF THE ESTROGEN-RESISTANT BREAST CANCER CELLS
by: S. E. Semina, et al.
Published: (2018-09-01)

CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES
by: О. Е. Andreeva, et al.
Published: (2019-11-01)

Effect of the exosome-mediated suppression of the estrogen signaling: the role in the progression of the hormonal resistance of breast cancer cells
by: D. V. Sorokin, et al.
Published: (2020-11-01)

MicroRNA-484 / Akt axis in the regulation of breast cancer cells sensitivity to antitumor drugs
by: O. E. Andreeva, et al.
Published: (2022-12-01)

Exosomes and development of cancer cell resistance to metformin: pilot study
by: S. E. Semina, et al.
Published: (2017-10-01)

INTERCELLULAR AND CELL-MATRIX INTERACTIONS IN BREAST CARCINOMA: THE PRESENT STATE OF PROBLEM
by: M. V. Mnikhovich, et al.
Published: (2018-04-01)

MicroRNA: sex steroids, hormonal carcinogenesis, hormonal sensitivity of tumor tissue
by: A. V. Malek, et al.
Published: (2015-06-01)

Estrogen-dependent signaling pathways and their role in the tumor progression: progress and perspectives
by: M. A. Krasil’nikov, et al.
Published: (2015-06-01)

ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
by: D. B. Erdyneeva, et al.
Published: (2020-09-01)

Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
by: V F Semiglazov, et al.
Published: (2009-09-01)

THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER
by: I. A. Koroleva, et al.
Published: (2018-08-01)

Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer
by: E. M. Slonimskaya, et al.
Published: (2018-10-01)

Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
by: V. I. Borisov
Published: (2014-07-01)

Ten-year adjuvant hormone therapy for breast cancer: the pros and cons (a review of literature)
by: S. M. Portnoy, et al.
Published: (2014-07-01)

The endometrium in women receiving adjuvant tamoxifen therapy after surgical treatment of breast cance
by: E V Dmitrieva, et al.
Published: (2013-12-01)

Role of microRNAs in breast cancer development and their potential as biomarkers
by: K. A. Grishina, et al.
Published: (2018-10-01)

8 let nadezhdy: novye dannye issledovaniya ATAS
by: - -
Published: (2008-03-01)

CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01)

Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020-06-01)

EXOSOMES AND TRANSFER OF (EPI)GENETIC INFORMATION BY TUMOR CELLS
by: E. M. Tchevkina, et al.
Published: (2015-12-01)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017-12-01)

Sovremennaya taktika ad\"yuvantnoy lekarstvennoy terapii bol'nykh operabel'nym (rannim) rakom molochnoy zhelezy
by: N I Perevodchikova
Published: (2007-06-01)

Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
by: A. V. Parnas, et al.
Published: (2021-09-01)

ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
by: N. N. Babyshkina, et al.
Published: (2017-06-01)

Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
by: N. S. Melnikova, et al.
Published: (2014-07-01)

EXOSOMES AND DEVELOPMENT OF TUMOR CELL RESISTANT PHENOTYPE
by: M. A. Krasilnikov, et al.
Published: (2018-05-01)

Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes)
by: - -
Published: (2008-03-01)

LEVELS OF HORMONES, microRNA AND CYTOKINES IN LYMPH FROM HEALTHY AND EXPERIMENTAL BREAST CANCER
by: A. P. Lykov, et al.
Published: (2016-11-01)

МИКРО-РНК КАК ПОТЕНЦИАЛЬНЫЕ НЕИНВАЗИВНЫЕ МАРКЕРЫ ПАТОЛОГИЧЕСКИХ СОСТОЯНИЙ ПЕЧЕНИ
by: В. П. Андреев, et al.
Published: (2023-12-01)

Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
by: Jaime D. Lewis, et al.
Published: (2014-11-01)

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
by: L. N. Lyubchenko, et al.
Published: (2017-10-01)

Drug treatment for metastatic breast cancer
by: E. V. Artamonova
Published: (2014-08-01)

Search for breast cancer proteomic markers in total blood exosomes
by: O. S. Tutanov, et al.
Published: (2020-04-01)

CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER
by: L. N. Lyubchenko, et al.
Published: (2017-12-01)

Practical guidelines for drug correction of diffuse dyshormonal dysplasia of the breast
by: I. V. Vysotskaya, et al.
Published: (2014-07-01)

Исследование миллиона женщин
Published: (2018-06-01)

Preoperative Hormone Therapy in the Treatment of Breast Cancer: What Do We Know So Far?
by: V. V. Vorotnikov, et al.
Published: (2022-10-01)

DISORDER OF INTERCELLULAR CORRELATIONS IN PATHOGENESIS OF FATTY TISSUE INFLAMMATION IN METABOLIC SYNDROME
by: I. A. Osikhov, et al.
Published: (2013-12-01)

Three benefits of toremifene, or a trend in the current hormone therapy
by: E. I. Borisova, et al.
Published: (2015-12-01)

[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications
by: A. V. Parnas, et al.
Published: (2021-06-01)